Please login to the form below

Brandcast Health shortlisted for Communiqué Award 2016

In partnership with Andrew Schorr, patient opinion leader and two-time cancer survivor, Brandcast Health developed online patient empowerment channel, The online digital resource designed specifically for patient education has been shortlisted for Excellence in Digital Communications (prescription products/patient health) at the 2016 Communiqué Awards.

The Excellence in Digital Communications – prescription products/patient health category commends innovative, well-designed and credible healthcare education or information programmes, delivered via an offline or online digital channel or channels to creatively and effectively communicate its message.

On news of the shortlist, Charlie Grieve, CEO commented:“Patients want a 360-degree view of their condition, so that they can get the best care for themselves. They want news, perspective, context, with all information up-to-date and credible. It takes time to develop trust and build patient-centric relationships and Pharma alone cannot deliver everything that patients want; they need to partner in order to deliver a sustained effort to educate, support and empower communities. Patient Power, addresses this unmet need for patients in finding reliable, trustworthy information online and provides a platform for partnership to enable Industry to act on their patient values. We are delighted that Patient Power Europe be recognised by clients and peers as a standout digital patient education initiative that has really delivered on all its objectives.”

For further information about Brandcast Health or Patient Power Europe, please contact Stephen Dunn or Charlie Grieve on +44(0)20 7291 5070.

29th June 2016


Company Details

Brandcast Health

+44 (0)20 7291 5070

Contact Website

16-17 Little Portland Street

Latest content on this profile

Day 2 Round-up from the Giant Health Event
Robin gives a quick overview of day 2 of the Giant Health Event.
Brandcast Health
Why patient education is important in oncology
We talked to Dr Bettina Ryll of Melanoma Patient Network Europe about changes in melanoma treatment and how the added complexity of new treatments has changed how patients need to be informed.
Brandcast Health
CABOSUN trial of cabozantinib – could it change how we treat frontline renal-cell carcinoma?
In the CABOSUN trial, cabozantinib was compared to sunitinib in treatment naive poor and intermediate risk renal-cell carcinoma (RCC) patients.
Brandcast Health
No surprises: results from the ENGOT-OV16/NOVA trial of niraparib in ovarian cancer
The ENGOT-OV16/NOVA trial of niraparib was a randomized, double-blinded placebo study with women with relapsed platinum-sensitive high-grade ovarian cancer.
Brandcast Health
FALCON trial of fulvestrant for advanced breast cancer
The Phase III FALCON trial compared fulvestrant to anastrozole for hormone receptor-positive advanced breast cancer.
Brandcast Health
Overview of the GIANT Health Event
Shafi Ahmed, PhD, FRCS, Director of Virtual Medics and Medical and GIANT Event Co-chair, provides an overview of the GIANT Health Event.
Brandcast Health